33 results on '"Marren, Amy"'
Search Results
2. Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
3. Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials
4. Ulcerative Colitis Treatment Patterns and Cost of Care
5. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
6. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
7. Patient and physician preferences for ulcerative colitis treatments in the United States
8. Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials
9. Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
10. Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply
11. Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
12. 836 Tofacitinib Efficacy in Patients With Moderate to Severe Ulcerative Colitis: Subgroup Analyses of OCTAVE Induction 1 & 2 and OCTAVE Sustain by 5-Aminosalicylates Use
13. Tu1720 – Efficacy of Tofacitinib Maintenance Therapy for Ulcerative Colitis in Remitting Patients Vs Patients with Clinical Response After 8 Weeks of Induction Treatment
14. Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
15. P030 Patient and physician preferences for ulcerative colitis treatments in the United States
16. Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.
17. Characterization of Creatine Kinase Levels in the Tofacitinib Ulcerative Colitis Development Program
18. Immunogenicity of biologics in inflammatory bowel disease
19. Pregnancy Outcomes in the Tofacitinib Ulcerative Colitis OCTAVE Studies
20. Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
21. Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
22. Systematic Literature Review on the Immunogenicity of Biologics in Inflammatory Bowel Disease
23. Tofacitinib Has Induction Efficacy in Moderately to Severely Active Ulcerative Colitis, Regardless of Prior TNF Inhibitor Therapy
24. Communication Between Physicians and Patients with Ulcerative Colitis: Insights from Studies of Patient-Doctor Visits
25. Onset of Efficacy of Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Multinational, Phase 3 Clinical Trials
26. Tu2003 Improvement in Patient-Reported Outcomes in Two Phase 3 Induction Studies of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis
27. 855 Efficacy and Safety of Tofacitinib for Oral Induction Therapy in Patients With Moderate to Severe Crohn's Disease: Results of a Phase 2B Randomized Placebo-Controlled Trial
28. 856 Efficacy and Safety of Oral Tofacitinib for Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: Results of a Phase 2B Randomized Placebo-Controlled Trial
29. Tofacitinib is not a biologic
30. Knowledge and understanding of menses inhibition or reduction in women and physicians
31. Tofacitinib is not a biologic.
32. What's your No. 1 tip for staying healthy on the road?
33. Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.